Real-world evaluation of bebtelovimab effectiveness during the period of COVID-19 Omicron variants, including BA.4/BA.5.

Authors:
Molina KC; Kennerley V; Beaty LE; Bennett TD; Carlson NE and 6 more

Journal:
Int J Infect Dis

Publication Year: 2023

DOI:
10.1016/j.ijid.2023.04.396

PMCID:
PMC10106116

PMID:
37072054

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Int J Infect Dis

Abbreviation: Int J Infect Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Communicable Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
An ancient coronavirus from individuals in France, circa 16th century.
Oumarou Hama H; Chenal T; Pible O and 3 more (2023) - Transparency Score: 4/6
Assessing the utility of pregnant women as a sentinel surveillance population for malaria in Geita,…
Munsey A; Kinyina A; Assenga M and 12 more (2023) - Transparency Score: 3/6
Association between nasopharyngeal colonization with multiple pneumococcal serotypes and total pneu…
Howard LM; Huang X; Chen W and 13 more (2023) - Transparency Score: 3/6
Autoantibodies against type I interferons in COVID-19 infection: A systematic review and meta-analy…
Wang X; Tang Q; Li H and 4 more (2023) - Transparency Score: 5/6
Characterization of the immune impairment of patients with tuberculosis and COVID-19 coinfection.
Najafi-Fard S; Aiello A; Navarra A and 10 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of competing interest The authors have no competing interests to declare."

Evidence found in paper:

"Funding This study was funded by the National Center for Advancing Translational Sciences of the US National Institutes of Health (grant numbers UL1TR002525, UL1TR002535-03S3, and UL1TR002535-04S2)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025